Interventions to be evaluated in this review (not exhaustive)
| Pharmacological interventions | Surgical and percutaneous interventions | |||
|---|---|---|---|---|
| Blood pressure-lowering drugs | Antiplatelet inhibitors | Lipid-lowering drugs | Oral hypoglycaemic agents | Procedures |
| Individual-based interventions | ||||
| ACE inhibitors | Aspirin | Atorvastatin | Metformin | Coronary artery bypass graft (CABG) |
| Angiotensin receptor blocker | Clopidogrel | Simvastatin | Sulfonylureas | Angioplasty |
| Calcium channel blockers | Fibrates | Insulin | Cardiac rehabilitation | |
| β-Blockers | Cardiac resynchronisation therapy (CRT) | |||
| Diuretics | Implantable cardioverter-defibrillator (ICD) | |||
| Polypill (fixed dose combination cardiovascular polypill) | Procedures to treat complications of diabetes: amputation, laser photocoagulation therapy etc. | |||
| Group/population-based interventions | ||||
| Health education | Health financingMultisectoral approach (eg, agricultural policy)Sin tax | High-risk screeningOpportunistic screeningGeneral/whole population screening | Peer-support interventions | Lifestyle behavioural counselling targeted at individual or population-based strategy: ▸ Physical activity ▸ Diet ▸ Tobacco cessation ▸ Alcohol consumption |